病态肥胖并非体外支持转运的禁忌证
该回顾性研究分析了2008年9月至2016年9月转运至本机构的222例体外膜氧合(ECMO)患者,比较非肥胖、肥胖和病态肥胖三组的结局。转运期间无死亡,出院生存率分别为66%、56%和82%(P=0.042),多因素分析显示体重指数并非院内死亡的预测因素(OR 0.99,95%CI 0.95-1.03;P=0.517)。作者认为在具备成熟管理方案的专职ECMO转运项目中,病态肥胖患者接受ECMO转运可能安全可行。
要点
- 病态肥胖患者接受ECMO转运期间无死亡,出院生存率为82%。
- 多因素分析显示体重指数并非院内死亡的预测因素(OR 0.99,95%CI 0.95-1.03;P=0.517)。
- 在专职ECMO转运项目且管理方案成熟的前提下,病态肥胖患者转运可能安全且结果良好。
核心结论
- 在具备成熟管理方案的专职ECMO转运项目中,病态肥胖患者接受ECMO转运可能安全进行且结果良好。
研究设计与样本
- 回顾性综述,纳入2008年9月至2016年9月转运至本机构并接受ECMO的全部患者,共222例。
- 肥胖定义为体重指数大于30 kg/m²,病态肥胖定义为体重指数大于40 kg/m²。
- 主要结局为成功脱机生存率和出院生存率。
主要发现
- 222例转运患者中,非肥胖131例(四分位距22-27 kg/m²),肥胖63例(四分位距31-35 kg/m²),病态肥胖28例(四分位距41-49 kg/m²),其中6例体重指数大于50 kg/m²(范围52.3-79 kg/m²)。
- 三组在ECMO前动脉血气、疾病严重程度指数、插管策略和转运距离方面相似。
- 转运期间无患者死亡;出院生存率非肥胖组为66%(n=87),肥胖组为56%(n=35),病态肥胖组为82%(n=23)(P=0.042)。
- 多因素logistic回归分析显示,体重指数并非院内死亡的预测因素(OR 0.99,95%CI 0.95-1.03;P=0.517)。
临床怎么用
- 原文结论认为,在专职ECMO转运项目且管理方案成熟的前提下,病态肥胖患者接受ECMO转运可能安全进行且结果良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) transport has not been described in morbidly obese patients, a population that can pose significant challenges in obtaining vascular access, indexed flows and transport logistics. We sought to study the feasibility and safety of transporting obese and morbidly obese patients during extracorporeal support. METHODS: We conducted a retrospective review of all patients transported to our institution while receiving ECMO from September 2008 to September 2016. Survival to decannulation and survival to discharge were the primary outcomes. Obesity and morbid obesity were defined as a body mass index of greater than 30 kg/m2 and greater than 40 kg/m2, respectively. RESULTS: From 2008 to 2016, 222 patients were transported to our institution while receiving ECMO. Among these included patients, 131 were non-obese (interquartile range 22-27 kg/m2), 63 were obese (interquartile range 31-35 kg/m2) and 28 were morbidly obese (interquartile range 41-49 kg/m2), with 6 patients having a body mass index greater than 50 kg/m2 (range 52.3-79 kg/m2). Pre-ECMO arterial blood gases, disease severity indices, cannulation strategies and transport distances were similar between these 3 groups. There was no mortality of patients during transport, and survival to discharge was 66% (n = 87) in non-obese patients, 56% (n = 35) in obese patients and 82% (n = 23) in morbidly obese patients (P = 0.042). On multivariable logistic regression analysis, body mass index was not a predictor of in-hospital mortality (odds ratio 0.99, 95% confidence interval 0.95-1.03; P = 0.517). CONCLUSIONS: Transport of morbidly obese patients receiving ECMO may be performed safely and with excellent results in the setting of a dedicated ECMO transport programme with well-established management protocols.
引用
- Salna M, Chicotka S, Biscotti M, et al. Morbid obesity is not a contraindication to transport on extracorporeal support. Eur J Cardiothorac Surg. 2018. PMID: 29253111. doi:10.1093/ejcts/ezx452
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。